Accurate de novo design of high-affinity protein binding macrocycles using deep learning The development of macrocyclic binders to therapeutic proteins typically relies on large-scale screening methods that are resource-intensive and provide little control over binding mode. Despite consi...

Check out the preprint co-authored by Dr. Gaurav Bhardwaj & Dr. David Baker

www.biorxiv.org/content/10.1...
#DrugDiscovery #GenerativeAI #MacrocyclicPeptides #Vilya